Dr. Rohit Bhatheja, MD

Dr. Bhatheja practices at Heart, Vascular and Metabolic Institute in Orlando, Florida.

Dr. Bhatheja's NPI, 1912097627, was assigned on October 13, 2006. Dr. Bhatheja graduated from Maulana Azad Medical College in 1999. Dr. Bhatheja holds Florida license ME107389.

Dr. Bhatheja's primary practice is Heart, Vascular and Metabolic Institute, at 9430 Turkey Lake Rd, Orlando, FL 32819 in Orange County. The practice phone is (407) 574-5161.

Dr. Bhatheja's primary practice is Heart, Vascular and Metabolic Institute in Orlando, Florida. Dr. Bhatheja is also affiliated with AdventHealth Orlando. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Bhatheja to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatheja practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Bhatheja's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Bhatheja is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bhatheja's licenses on file in 4 states: Florida, Kentucky, Pennsylvania and Ohio.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Bhatheja treats.

CMS data shows 5,337 Medicare services from Dr. Bhatheja across 28 procedure codes in 2024, for 1,887 Medicare patients. Medicare paid $378,173 for them.

CMS counts 1,887 Medicare patients who saw Dr. Bhatheja in 2024. The largest group is 75 to 84, with 760 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatheja's median patient age at 71, with 46% women.

In 2024, Dr. Bhatheja wrote 8,117 Medicare Part D claims for 1,049 patients. 81% of them were for generic drugs. CMS names the drug for 7,891 of them, across 68 drugs with 11 or more claims each, at $1,658,048 in total drug cost. In 2023, CMS named 5,302 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Bhatheja for performance year 2024, reported as part of a group. Dr. Bhatheja accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhatheja as offering telehealth. CMS counts 37 procedures of coronary angioplasty and stenting by Dr. Bhatheja, more than 73% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Bhatheja, published from 2020 to 2023. 2020 was the busiest year, with 2. The most frequent topics are Atherectomy, Coronary, Equipment Design and Fibrinolytic Agents. Dr. Bhatheja has published most often in Circ Cardiovasc Interv. Dr. Bhatheja's most frequent co-authors are Kannan Natarajan, MD, Gregory Piazza, MD and Riyaz Bashir, MD.

Dmand AI links Dr. Bhatheja to 9 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Pulmonary Embolism, Coronary Artery Disease and Embolism. Abbott Medical Devices sponsors the most, 4.

CMS Open Payments shows 519 general payments to Dr. Bhatheja from 47 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $57,562.

Dmand AI lists 2 awards for Dr. Bhatheja, most recently CMS Stage 1 2012 in 2011.

Dr. Bhatheja graduated from Maulana Azad Medical College in 1999. Dr. Bhatheja is a member of ACC.

Dr. Bhatheja is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.